"Apathy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Lack of emotion or emotional expression; a disorder of motivation that persists over time.
Descriptor ID |
D057565
|
MeSH Number(s) |
F01.470.137
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Apathy".
Below are MeSH descriptors whose meaning is more specific than "Apathy".
This graph shows the total number of publications written about "Apathy" by people in this website by year, and whether "Apathy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2011 | 1 | 0 | 1 |
2013 | 3 | 0 | 3 |
2015 | 0 | 1 | 1 |
2016 | 0 | 1 | 1 |
2018 | 3 | 0 | 3 |
2019 | 0 | 1 | 1 |
2020 | 2 | 0 | 2 |
2021 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Apathy" by people in Profiles.
-
Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial. JAMA Neurol. 2021 11 01; 78(11):1324-1332.
-
Diagnostic criteria for apathy in neurocognitive disorders. Alzheimers Dement. 2021 12; 17(12):1892-1904.
-
Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments. Am J Geriatr Psychiatry. 2021 01; 29(1):81-89.
-
Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate. Am J Geriatr Psychiatry. 2021 01; 29(1):51-62.
-
An adjunctive human-animal interaction intervention for veterans with PTSD: study protocol for a randomized controlled trial. Trials. 2019 Dec 27; 20(1):786.
-
Dopaminergic dose adjustment and negative affective symptoms after deep brain stimulation. J Neurol Sci. 2018 07 15; 390:33-35.
-
The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial. Trials. 2018 Jan 18; 19(1):46.
-
Psychometric Properties of Apathy Scales in Dementia: A Systematic Review. J Alzheimers Dis. 2018; 66(3):1065-1082.
-
Changes in Neuropsychiatric Inventory Associated with Semagacestat Treatment of?Alzheimer's Disease. J Alzheimers Dis. 2016 08 10; 54(1):373-81.
-
Reward circuit DBS improves Parkinson's gait along with severe depression and OCD. Neurocase. 2016; 22(2):201-4.